Skip to content

Frontlight ResearchEarly access

Trial site

Beijing Tiantan Hospital

Beijing, Beijing Municipality 100070, ChinaNot linked to an institution yet

77running trials
11closed trials

The trials here

What the 89 trials at this site are about, from their registry records.

Conditions: Stroke44 trials
Glioblastoma7 trials
Migraine6 trials
Brain aneurysm5 trials
Insomnia4 trials
ALS (motor neurone disease)3 trials
Alzheimer disease3 trials
Osteoarthritis3 trials
Delirium2 trials
Epilepsy2 trials
High blood pressure2 trials
Irritable bowel syndrome2 trials
and 9 more
Phase: Phase 39 trials
Phase 27 trials
Early phase 16 trials
Phase 15 trials
Phase 1/23 trials
Phase 42 trials
Phase 2/31 trial
Status: Recruiting50 trials
Not yet recruiting18 trials
Completed11 trials
Active, not recruiting5 trials
Enrolling by invitation4 trials
Suspended1 trial
Lead sponsor: Beijing Tiantan Hospital68 trials
yilong Wang4 trials
Beijing Municipal Administration of Hospitals2 trials
Beijing Neurosurgical Institute2 trials
Deling Li1 trial
and 12 more

Running trials

Not yet recruiting
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke
NCT07754825· Phase 2· Shanghai Pharmaceuticals Holding Co., Ltd· Source
Contact: Yongjun Wang
Not yet recruiting
Drug-Coated Balloon vs Aggressive Medical Management for High-Risk Symptomatic Intracranial Atherosclerotic Stenosis
NCT07830277· Beijing Tiantan Hospital· Source
Contact: Changchun Jiang, MD
Not yet recruiting
A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke
NCT07645586· Phase 3· Beijing Tiantan Hospital· Source
Contact: Lingling Ding, MD
Recruiting
High-density Flexible μECoG for Epilepsy Surgery - A Single-Arm ECT
NCT07656857· Beijing Tiantan Hospital· Source
Contact: Du Cai Dr
Not yet recruiting
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke
NCT07645560· Phase 2· Beijing Tiantan Hospital· Source
Contact: Lingling Ding, MD
Recruiting
Development and Validation of Risk Prediction Models for Stroke and Cognitive Impairment in Moyamoya Disease and Moyamoya Syndrome
NCT07894107· Beijing Tiantan Hospital· Source
Contact: Qian Zhang
Recruiting
Expansion Study of ALT001 in Patients With Multiple System Atrophy
NCT07476352· Early phase 1· yilong Wang· Source
Contact: Zhu Yahui
Recruiting
The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type
NCT07514923· Early phase 1· yilong Wang· Source
Contact: Weiqi Chen
Not yet recruiting
Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit
NCT07670065· Phase 3· Beijing Tiantan Hospital· Source
Contact: Xuewei Xie, Dr.
Recruiting
Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis
NCT07526987· Phase 3· Beijing Tiantan Hospital· Source
Contact: Anxin Wang, PhD
Recruiting
HBO After Thrombectomy for AIS With LVO
NCT07626450· Beijing Tiantan Hospital· Source
Contact: Ning Ma, MD
Not yet recruiting
The Feasibility and Safety of RK-4 Injection Bypassing Blood-brain Barrier in the Treatment of Acute Large Hemispheric Infarction Using Intracalvariosseous Injection Device
NCT07514949· yilong Wang· Source
Contact: Yilong Wang, PhD+MD
Recruiting
Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic Stroke
NCT07423975· Phase 2· Beijing Tiantan Hospital· Source
Contact: Yunyun Xiong, professor
Recruiting
Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome
NCT07635394· Beijing Tiantan Hospital· Source
Contact: Fang Luo
Not yet recruiting
Advancing Reperfusion Therapy for Ischemic Stroke: Direct Transfer to Angiography Suite for Patients With Suspected Large Vessel Occlusion
NCT07460713· Beijing Tiantan Hospital· Source
Contact: Yunyun Xiong
Not yet recruiting
Emergency Stroke Unit With NeuAngio-CT (ESU-ACT)
NCT07456228· Beijing Tiantan Hospital· Source
Contact: Xuewei Xie, Dr.
Recruiting
Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusion Therapy
NCT07323368· Beijing Tiantan Hospital· Source
Contact: Yunyun Xiong, professor
Recruiting
Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia
NCT07311343· Phase 4· Beijing Tiantan Hospital· Source
Contact: Junping Guo
Active, not recruiting
Prediction Model for Postoperative Headache After Transsphenoidal Pituitary Surgery
NCT07446036· Beijing Tiantan Hospital· Source
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Cervicogenic Headache
NCT07347730· Beijing Tiantan Hospital· Source
Contact: Fang Luo
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Shoulder Osteoarthritis(OA)
NCT07347054· Beijing Tiantan Hospital· Source
Contact: Fang Luo
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Migraine
NCT07347067· Beijing Tiantan Hospital· Source
Contact: Fang Luo
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Hip Osteoarthritis(OA)
NCT07347041· Beijing Tiantan Hospital· Source
Contact: Fang Luo
Recruiting
Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China
NCT07143149· Beijing Tiantan Hospital· Source
Contact: Jie Xu
Recruiting
Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Knee Osteoarthritis(OA)
NCT07347028· Beijing Tiantan Hospital· Source
Contact: Fang Luo
Not yet recruiting
RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction
NCT07166380· Phase 1/2· Neurodawn Pharmaceutical Co., Ltd.· Source
Contact: lilong wang
Enrolling by invitation
Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma
NCT07520214· Early phase 1· Beijing Neurosurgical Institute· Source
Recruiting
Development and Validation of Delirium Recognition Using Computer Vision in Neuro-critical Patients
NCT07136207· Beijing Tiantan Hospital· Source
Contact: Shi Guangzhi Department Director, Doctoral degree
Active, not recruiting
The Safety,Tolerability, Efficacy of XS411 Cell Injection for the Treatment of Primary Parkinson's Disease
NCT07080775· Phase 1/2· XellSmart Therapeutics (Shanghai) Co., Ltd.· Source
Recruiting
Environmental Pollutants and Neurological Disorders
NCT07140601· Beijing Tiantan Hospital· Source
Contact: Runting Li, MD
Recruiting
Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke
NCT07047014· Phase 3· Beijing Tiantan Hospital· Source
Contact: Yunyun Xiong
Recruiting
MRgLITT for mTLE: A PROBE Trial
NCT06720922· Beijing Tiantan Hospital· Source
Contact: Jiajie Mo, Dr.
Recruiting
Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ
NCT06414499· Phase 3· Beijing Tiantan Hospital· Source
Contact: Yongjun Wang, Dr.
Not yet recruiting
AI-Driven Early Warning System for Perioperative Risks in Acute Hemorrhagic Stroke
NCT06998082· Beijing Tiantan Hospital· Source
Contact: ming yu Peng, M.D, Ph.D
Recruiting
ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
NCT07177482· Deling Li· Source
Contact: Deling Li, MD
Not yet recruiting
Remote Ischemic Conditioning for Efficacy in Patients With Aneurysmal Subarachnoid Hemorrhage
NCT06711302· Beijing Tiantan Hospital· Source
Contact: Aihua Liu, Doctor
Recruiting
Changes in Etomidate Dosage in Patients With Insomnia Undergoing Intravenous Anesthesia
NCT07028177· Beijing Tiantan Hospital· Source
Contact: Fang Luo, M.D.
Recruiting
Changes in Rimazolen Dosage in Patients With Insomnia Under Intravenous Anesthesia
NCT07028190· Beijing Tiantan Hospital· Source
Contact: Fang Luo, M.D.
Recruiting
Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND
NCT06954155· Phase 3· Beijing Tiantan Hospital· Source
Contact: Yongjun Wang
Recruiting
Alzheimer's Disease Treated With Vagus Nerve Stimulation
NCT06923007· Beijing Municipal Administration of Hospitals· Source
Contact: Rujin Wang
Recruiting
BC008-1A Injection for Recurrent CNS WHO G4 Glioma
NCT06773481· Phase 1· Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.· Source
Contact: Di Wang, MD
Recruiting
Application of QDSA Platform in Cerebrovascular Diseases
NCT06902415· Beijing Tiantan Hospital· Source
Contact: Yu Chen, MD
Recruiting
Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia
NCT06890897· Beijing Tiantan Hospital· Source
Contact: Fang Luo, M.D
Recruiting
Changes in Ciprofol Dosage in Patients With Insomnia Undergoing Intravenous Anesthesia
NCT06897007· Beijing Tiantan Hospital· Source
Contact: Fang Luo, M.D.
Recruiting
Aleeto in Acute ISchemic Stroke：A RandomISed Controlled Clinical Trial
NCT06759753· Phase 2· Beijing Tiantan Hospital· Source
Contact: Yilong Wang
Recruiting
Safety , Feasibility and Preliminary Efficacy of Remote Ischemic Conditioning in Patients With Aneurysmal Subarachnoid Hemorrhage After Aneurysm Clipping
NCT06819657· Beijing Tiantan Hospital· Source
Contact: Aihua Liu, Doctor
Recruiting
Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System
NCT06783049· Beijing Tiantan Hospital· Source
Contact: Zhiyuan Feng
Recruiting
Efficacy of Esketamine for Patients With Irritable Bowel Syndrome
NCT06788444· Beijing Tiantan Hospital· Source
Contact: Fang Luo, M.D
Recruiting
Safety and Preliminary Efficacy of NXL-001 in Patients With Ischemic Stroke
NCT06761183· Early phase 1· Beijing Tiantan Hospital· Source
Contact: Zhu Yahui
Recruiting
Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease
NCT06925178· Beijing Tiantan Hospital· Source
Contact: wenjie wang

Showing 50 of 77.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Stroke38 recruiting
Migraine6 recruiting
Glioblastoma4 recruiting
Insomnia4 recruiting
Osteoarthritis3 recruiting
ALS (motor neurone disease)2 recruiting
Alzheimer disease2 recruiting
Brain aneurysm2 recruiting
Delirium2 recruiting
Epilepsy2 recruiting
High blood pressure2 recruiting
Irritable bowel syndrome2 recruiting
Multiple system atrophy2 recruiting
Childhood cancers1 recruiting
Dystonia1 recruiting
Multiple sclerosis1 recruiting
Neuromyelitis optica (NMOSD)1 recruiting
Parkinson disease1 recruiting
Trigeminal neuralgia1 recruiting

Closed trials

Completed
A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke
NCT07205328· Phase 2· Shaanxi Micot Pharmaceutical Technology Co., Ltd.· Source
Completed
Lesion Network MApping Navigated Continuous Theta-burst STimulation for Motor REcovery in Acute Ischemic Stroke
NCT06400407· Phase 2· Beijing Tiantan Hospital· Source
Completed
Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair
NCT06238115· Phase 2/3· Beijing Tiantan Hospital· Source
Completed
Safety and Tolerance of RAG-17 in Amyotrophic Lateral Sclerosis Patients With SOD1 Gene Mutation
NCT05903690· Early phase 1· Beijing Tiantan Hospital· Source
Completed
Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke
NCT05836740· Phase 3· Beijing Tiantan Hospital· Source
Completed
Y-3 Injection Through Skull Bone Marrow in the Treatment of Acute Malignant Middle Cerebral Artery Infarction (SOLUTION)
NCT05849805· Beijing Tiantan Hospital· Source
Completed
Evaluating the Safety and Efficacy of the Maurora® DES in ICAS
NCT05719883· Beijing Tiantan Hospital· Source
Completed
Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on Regional Medical Centers in China and Population Follow-up Study (Phase Ⅱ)
NCT05608122· Beijing Tiantan Hospital· Source
Completed
Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
NCT04968366· Phase 1· Beijing Tiantan Hospital· Source
Completed
The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection
NCT04595786· Beijing Tiantan Hospital· Source
Completed
Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma
NCT06562621· Phase 1/2· Beijing Neurosurgical Institute· Source

Site data: ClinicalTrials.govUpdated 15 Nov 2026

Report an error